According to Cytokinetics 's latest financial reports the company's current revenue (TTM) is $7.53 M. In 2022 the company made a revenue of $94.58 M an increase over the years 2021 revenue that were of $70.42 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $7.53 M | -92.04% |
2022 | $94.58 M | 34.3% |
2021 | $70.42 M | 26.15% |
2020 | $55.82 M | 107.79% |
2019 | $26.86 M | -14.71% |
2018 | $31.5 M | 135.64% |
2017 | $13.36 M | -87.44% |
2016 | $0.10 B | 271.3% |
2015 | $28.65 M | -38.95% |
2014 | $46.94 M | 53.16% |
2013 | $30.64 M | 305.45% |
2012 | $7.55 M | 88.98% |
2011 | $4 M | 55.28% |
2010 | $2.57 M | -96.84% |
2009 | $81.53 M | 556.5% |
2008 | $12.42 M | -8.82% |
2007 | $13.62 M | 335.63% |
2006 | $3.12 M | -64.91% |
2005 | $8.91 M | -33.7% |
2004 | $13.44 M | 26.92% |
2003 | $10.59 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Amgen AMGN | $28.19 B | 374,269.19% | ๐บ๐ธ USA |
Trevena TRVN | $3.2 M | -57.41% | ๐บ๐ธ USA |
Ligand Pharmaceuticals LGND | $0.13 B | 1,643.88% | ๐บ๐ธ USA |
Acorda Therapeutics
ACOR | $0.11 B | 1,462.19% | ๐บ๐ธ USA |
Array Technologies ARRY | $1.57 B | 20,836.93% | ๐บ๐ธ USA |